Optimal irradiation field setting and prescribed dose in carbon-ion radiotherapy for sinonasal mucosal melanoma

Optimal irradiation field setting and prescribed dose in carbon-ion radiotherapy for sinonasal mucosal melanoma - carbon-ion radiotherapy for sinonasal mucosal melanoma

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000045603

Enrollment

150

Registered

2021-09-30

Start date

2021-09-17

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sinonasal mucosal melanoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Sinonasal Mucosal melanoma patients who were prospectively enrolled in in-hospital treatment protocols 0007 and 0007 (2) from July 2001 to February 2018 and were treated with carbon-ion radiotherapy combined with DAV chemotherapy, which is a protocol treatment.

Exclusion criteria

Exclusion criteria: Refusal of use of clinical data for this study by the study subject or his / her agent.

Design outcomes

Primary

Measure	Time frame
Relationship between local recurrence site, irradiation field, and prescribed dose.	—

Secondary

Measure	Time frame
Local control rate, overall survival rate, progression-free survival rate, late adverse event occurrence rate.	—

Countries

Japan

Contacts

Public ContactMasashi Koto

National Institutes for Quantum Sciences and Technology QST Hospital

koto.masashi@qst.go.jp043-206-3306

Outcome results